Menu

Drugmaker Novartis has announced it will refund 340B providers for more than 100 products after adjusting their 340B ceiling prices.

Novartis to Refund Covered Entities After Adjusting 340B Ceiling Prices for 100-Plus Products

April 23, 2024 Views

Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young